. 2014 Jul 28;6(5):354–361. doi: 10.14740/jocmr1863w

Table 3. Biochemical Marker Levels in the Control Group and in Patients Before and After Statin Treatment (Mean ± SD) .

	Control (n = 26)	Patient before treatment (n = 30)	Patient 3 months after treatment (n = 30)	Control 3 months after follow-up
E-selectin (ng/mL)	78.66 ± 24.74	99.74 ± 34.67^a	89.15 ± 30.50*	81.3 ± 26.3
sICAM-1 (ng/mL)	387.5 ± 113.5	568.8 ± 149.0^a	490.2 ± 133.0*	422 ± 123.2^b
Endothelin (fmol/mL)	0.69 ± 0.33	0.62 ± 0.33	0.55 ± 0.20	0.62 ± 0.21
hs-CRP (mg/L)	1.07 ± 0.79	21.30 ± 39.10^a	3.01 ± 0.83**	2.2 ± 0.81^b

E-selectin: endothelial selectin; sICAM-1: soluble intercellular adhesion molecule; hs-CRP: high-sensitivity C-reactive protein. ^aP < 0.001 patient vs. control group at baseline. ^bP < 0.05 patient vs. control group at the 3-month follow-up. *P < 0.001, **P < 0.05 pre- vs. post-treatment in the patient group.